Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Craig Haytmanek

Orthopaedic Surgery Vail, CO Medical Doctor

NPI 1457519795 CMS profile 461848

181 W Meadow Dr Ste 400, Vail, CO 81657

Open in the dashboard

General payments

$181,880

318 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$221,967 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Craig Haytmanek of Vail, CO is reported in the CMS Open Payments database as having received $181,880 across 318 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $221,967 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $52,120 39
2024 General $25,016 36
2023 General $49,260 79
2022 General $22,675 44
2021 General $8,882 37
2020 General $2,499 13
2019 General $21,429 70

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Craig Haytmanek
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Craig Haytmanek were reported at $52,120. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Craig Haytmanek Orthopaedic Surgery median Middle half National median
2019 $21,429 $644 $140–$2,844 $163
2020 $2,499 $312 $75–$1,860 $114
2021 $8,882 $520 $117–$2,495 $132
2022 $22,675 $598 $128–$2,731 $149
2023 $49,260 $461 $128–$2,264 $160
2024 $25,016 $497 $134–$2,475 $164
2025 $52,120 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $177,269 269 payments
  2. Stryker Corporation $1,543 18 payments
  3. Gemini Mountain Medical, LLC $1,526 7 payments
  4. Exactech, Inc. $679 6 payments
  5. Bioventus LLC $168 5 payments
  6. Smith+Nephew, Inc. $143 2 payments
  7. Gemini Medical LLC $125 1 payment
  8. Wright Medical Technology, Inc. $120 4 payments
  9. Ossur Americas., Inc $117 1 payment
  10. Steelhead Surgical Inc $107 2 payments
  11. Other $84 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $97,793 41 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $48,069 22 payments
  3. Travel and Lodging $26,200 85 payments
  4. Food and Beverage $8,853 169 payments
  5. Education $965 1 payment
Products named General payments · program years 2019–2025
  1. DISTAL EXTREMITIES IMPLANTS SOFT TISSUE IB LIGAMENT AUGMENTATION $7,520 12 payments
  2. DISTAL EXTREMITIES IMPLANTS HINDFOOT & ANKLE ANKLE ARTHROPLASTY $1,219 1 payment
  3. INFINITY $941 10 payments
  4. INBONE $781 8 payments
  5. PROPHECY $778 8 payments
  6. VANTAGE $661 5 payments
  7. DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ACHILLES $275 4 payments
  8. INFINITY ADAPTIS $250 3 payments
  9. DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ANCHORS $188 1 payment
  10. DISTAL EXTREMITIES INSTRUMENTS CORE METAL HINDFOOT & ANKLE $188 1 payment
  11. Other $2,023 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 89 billing codes

Paid by Medicare

$111,866

Of which drugs: $278

Medicare patients

253

Average age 72

Services billed

1,218

141 women, 112 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 72%
High blood pressure 42%
Ischemic heart disease 25%
Osteoporosis 16%
Atrial fibrillation 11%
Cancer 11%
Depression 11%
Chronic kidney disease 7%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 50 215 $160

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

318 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record